Role of CD8(+) T cells in mycobacterial infections

Immunology and Cell Biology

Volumn 78, Issue 4, 2000, Pages 325-333

  Smith, S M ^a   Dockrell, H M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

CD8; Infection; Interferon ; Mycobacteria; Mycobacterium tuberculosis; T cell

Indexed keywords

BCG VACCINE; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN RECOGNITION; BCG VACCINATION; CYTOLYSIS; HUMAN; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REVIEW; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BCG VACCINE; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC TECHNIQUES; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; VACCINES, ATTENUATED; VACCINES, DNA; VACCINES, SYNTHETIC;

ANIMALIA; CORYNEBACTERINEAE; MURINAE; MYCOBACTERIUM; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 0033842323     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.2000.00936.x     Document Type: Review

References (105)

1. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice
2. T cell responses to Mycobacterium tuberculosis
3. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection
4. Patterns of cytokine production by Mycobacterium tuberculosis-reactive human T-cell clones
5. + T-cell clones: Heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes
6. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection
7. Immune response to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II-deficient knock-out mice: Contribution of CD4 and CD8 T cells to acquired resistance
8. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis
9. Specificity of proliferative response of human CD8 clones to mycobacterial antigens
10. Protective role for CD8 cells in tuberculosis
11. + T cells in vitro
12. Proliferation of distinct human T cell subsets in response to live, killed or soluble extracts of Mycobacterium tuberculosis and Mycobacterium avium
13. + cytotoxic T cells and relative resistance of alveolar macrophages to lysis
14. Differential effect of cytolytic T cell subsets on intracellular infection
15. + T cells reactive with Mycobacterium tuberculosis-infected antigen presenting cells
16. - cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway
17. +T cells
18. Antigen processing and presentation by the class I major histocompatibility complex
19. Mechanisms of MHC class I-restricted antigen processing
20. Degradation of cell proteins and the generation of MHC class I-presented peptides
21. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses
22. Antigen presentation by CD1 and MHC-encoded class I-like molecules
23. CD 1, tuberculosis, and the evolution of major histocompatibility complex molecules
24. The role of CD1 molecules in immune response to infection
25. Isolation of Mycobacterium-reactive CD1-restricted T cells from patients with human immunodeficiency virus infection
26. - T cell pool
27. Characterisation of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited
28. Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route
29. Characterisation of a haemolysin from Mycobacterium tuberculosis with homology to a virulence factor of Serpulina hyodysenteriae
30. Mycobacterial infection of macrophages results in membrane-permeable phagosomes
31. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection
32. Enhancement of the human T cell response to culture filtrate fractions of Mycobacterium tuberculosis by microspheres
33. Generation of polarised antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles
34. + T cells into subpopulations with distinct cytokine profiles
35. CD8 Tc1 and Tc2 cells secrete distinct cytokine patterns in vitro and in vivo but induce similar inflammatory reactions
36. + T cells secreting Th1 or Th2 cytokines
37. + T cells limits their cytokine synthesis and proliferation
38. Human Tc1 and Tc2/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes
39. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones
40. Disseminated tuberculosis in interferon gene-disrupted mice
41. An essential role for interferon in resistance to Mycobacterium tuberculosis infection
42. + T cells from patients with tuberculosis is related to the presence of pulmonary cavities
43. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells
44. An antimicrobial activity of cytolytic T cells mediated by granulysin
45. Processing, subcellular localisation, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins
46. Granulysin-induced apoptosis: Involvement of at least two distinct pathways
47. Host defence against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells
48. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice
49. The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms
50. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice
51. + T cells requires the production of gamma interferon
52. +, T cells in the lungs following aerosol infection with Mycobacterium tuberculosis
53. + T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice
54. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Polspecific CD8 T cells in HIV-1-positive individuals
55. + responses to Epstein-Barr virus antigens
56. + T cells specific for EBin healthy virus carriers
57. + memory T cells
58. Quantification of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA
59. + T cells during the primary response to Epstein-Barr virus in vivo
60. - T cells in individuals receiving highly active antiretroviral therapy (HAART)
61. + T cells with soluble HLA-A2/Tax11-19 tetramer complexes in patients with human T cell lymphotrophic virus-associated myelopathy
62. +T cells in peripheral blood and liver using peptide-MHC tetramers
63. Characterisation of circulating T cells specific for tumor-associated antigens in melanoma patients
64. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
65. Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy
66. Longitudinal phenotypic analysis of human immunodeficiency virus Type 1-specific cytotoxic T lymphocytes Correlation with disease progression
67. Modern vaccines. Mycobacterial disease
68. New concepts for the control of tuberculosis in the twenty first centuary
69. Human T cell responses induced by vaccination with Mycobacterium bovis BCG
70. Auxotrophic vaccines for tuberculosis
71. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine
72. Vaccination of guinea pigs with nutritionally impaired avirulent mutants of Mycobacterium bovis protects against tuberculosis
73. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene
74. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: Effect on growth in culture and macrophages
75. Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes
76. Introduction of protein or DNA delivered via recombinant Salmonella typhimurium into the major histocompatibility complex class I presentation pathway of macrophages
77. Vaccination with recombinant vaccinia virus protects mice against Mycobacterium tuberculosis infection
78. + cytotoxic T cells specific for macrophages infected with Mycobacterium tuberculosis
79. Immunotherapy with Mycobacterium vaccae in patients with newly diagnosed pulmonary tuberculosis: A randomised controlled trial
80. Randomised controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected Ugandan adults with newly diagnosed pulmonary tuberculosis
81. Vaccination against tuberculosis by DNA injection
82. Therapy of tuberculosis in mice by DNA vaccination
83. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine
84. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis
85. + T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection
86. T-cell-epitope mappin of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy
87. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
88. Key epitopes on the ESAT-6 antigen recognised in mice during recall of protective immunity to Mycobacterium tuberculosis
89. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis
90. E SAT-6 subunit vaccination against Mycobacterium tuberculosis
91. Co-immunisation with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T cell immunity, but not protective efficacy against Mycobacterium tuberculosis
92. The immunogenicity of single and combination DNA vaccines against tuberculosis
93. + T lymphocytes specific for Mycobacterium tuberculosis
94. CTL response to Mycobacterium tuberculosis: Identification of an immunogenic epitope in the 19-kDa lipoprotein
95. + CTL recognising mycobacterial peptides
96. b mice recognising the 38 kDa antigen of Mycobacterium tuberculosis
97. Identification of new cytotoxic T cell epitopes on the 38-kilodalton lipoglyco-protein of Mycobacterium tuberculosis by using lipopeptides
98. Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice
99. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
100. + T cells in healthy contacts I of tuberculosis
101. Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection
102. Development of a whole blood assay to measure T cell responses to leprosy: A new tool for immuno-epidemiological field studies of leprosy immunity
103. Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects
104. The immune response to Mycobacterium tuberculosis in HIV-infected and uninfected adults in Uganda Application of a whole blood cytokine assay in an epidemological study
105. Activation changes the spectrum but not the diversity of genes expressed by T cells